Cytotoxicity and reversal of multidrug resistance by tryptanthrin-derived indoloquinazolines
- 5 February 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Pharmacologica Sinica
- Vol. 31 (2), 259-264
- https://doi.org/10.1038/aps.2009.198
Abstract
To evaluate the effects and elucidate the mechanisms of a series of indoloquinazolines as novel anticancer agents. Condensation of the substituted isatoic anhydride with the substituted isatin was performed to prepare compounds 1–4, followed by adding malononitrile to prepare compounds 5–7. Cytotoxicity was measured by MTT assays. Apoptosis induction was evaluated using DNA fragmentation, cell cycle assay, caspase 3/7 activity and Western blot. Compounds 3, 4, and 5 display cytotoxicity against MCF-7, HeLa, SKOV3, and A498 cancer cells. DNA ladders appear in cells treated with compounds 3, 4, and 5. Within those, compound 4 exhibits the greatest activity in regards to sub-G1 accumulations in the cell cycle and the activation of caspase-3/7. Furthermore, Fas and Fas ligand levels are elevated by compound 4, implying that the apoptosis is in part mediated through the signals. On the other hand, compounds 1 and 7 display chemosensitizing activity since cytotoxicity of doxorubicine and etoposide is enhanced in combination with compound 1 and 7, respectively, in MCF-7/adr (doxorubicin-resistant) and MCF-7/vp (etoposide-resistant). The cytotoxicity of indoloquinazolines is structure-dependent rather than cell type-dependent due to the similar degree of cytotoxicity induced by the individual compounds in all four cell lines. Further modification of the tryptanthrin skeleton is important to develop novel anticancer agents bearing either cytotoxicity against MCF-7 cells or drug resistance reversal in MCF-7/adr and MCF-7/vp.Keywords
This publication has 23 references indexed in Scilit:
- Cell Death: History and FutureAdvances in experimental medicine and biology, 2008
- Strategies for Inhibition of MDR1 Gene ExpressionMolecular Pharmacology, 2004
- Apoptosis pathways in cancer and cancer therapyCancer Immunology, Immunotherapy, 2004
- Death receptor-induced cell killingCellular Signalling, 2003
- Novel indolo[2,1-b]quinazoline analogues as cytostatic agents: synthesis, biological evaluation and structure–activity relationshipBioorganic & Medicinal Chemistry Letters, 2002
- Cell differentiation and apoptosis of monocytic and promyelocytic leukemia cells (U‐937 and HL‐60) by tryptanthrin, an active ingredient of Polygonum tinctorium Lour.Pathology International, 2001
- Tryptanthrin inhibits nitric oxide and prostaglandin E2 synthesis by murine macrophagesEuropean Journal of Pharmacology, 2000
- The biochemistry of apoptosisNature, 2000
- Fas Ligand-Induced ApoptosisAnnual Review of Genetics, 1999
- Isolation of Antifungal Principle Tryptanthrin, from Strobilanthes Cusia O. KuntzePlanta Medica, 1979